Annual Shareholders Equity
$233.56 M
+$57.11 M+32.36%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual stockholders equity is $233.56 million, with the most recent change of +$57.11 million (+32.36%) on December 31, 2022.
- During the last 3 years, EGRX annual shareholders equity has risen by +$54.39 million (+30.35%).
- EGRX annual shareholders equity is now at all-time high.
Performance
EGRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$252.04 M
+$9.20 M+3.79%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly stockholders equity is $252.04 million, with the most recent change of +$9.20 million (+3.79%) on June 30, 2023.
- Over the past year, EGRX quarterly shareholders equity has increased by +$14.06 million (+5.91%).
- EGRX quarterly shareholders equity is now at all-time high.
Performance
EGRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EGRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.4% | +5.9% |
| 3 y3 years | +30.4% | +37.0% |
| 5 y5 years | +30.4% | +35.7% |
EGRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.4% | at high | +42.8% |
| 5 y | 5-year | at high | +32.4% | at high | +45.9% |
| alltime | all time | at high | +2030.6% | at high | >+9999.0% |
Eagle Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $252.04 M(+3.8%) |
| Mar 2023 | - | $242.84 M(+4.0%) |
| Dec 2022 | $233.56 M(+32.4%) | $233.56 M(+0.8%) |
| Sep 2022 | - | $231.78 M(-2.6%) |
| Jun 2022 | - | $237.98 M(+10.2%) |
| Mar 2022 | - | $215.96 M(+22.4%) |
| Dec 2021 | $176.45 M(-5.1%) | $176.45 M(-4.8%) |
| Sep 2021 | - | $185.29 M(-4.9%) |
| Jun 2021 | - | $194.85 M(+2.0%) |
| Mar 2021 | - | $191.08 M(+2.7%) |
| Dec 2020 | $186.01 M(+3.8%) | $186.01 M(+7.7%) |
| Sep 2020 | - | $172.79 M(-6.1%) |
| Jun 2020 | - | $183.96 M(+1.2%) |
| Mar 2020 | - | $181.83 M(+1.5%) |
| Dec 2019 | $179.17 M(+11.5%) | $179.17 M(+1.9%) |
| Sep 2019 | - | $175.76 M(+1.9%) |
| Jun 2019 | - | $172.48 M(-1.6%) |
| Mar 2019 | - | $175.36 M(+9.1%) |
| Dec 2018 | $160.76 M | $160.76 M(-17.2%) |
| Sep 2018 | - | $194.06 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $185.73 M(+4.2%) |
| Mar 2018 | - | $178.18 M(-0.5%) |
| Dec 2017 | $179.14 M(+18.5%) | $179.14 M(+4.7%) |
| Sep 2017 | - | $171.08 M(+3.5%) |
| Jun 2017 | - | $165.36 M(-0.9%) |
| Mar 2017 | - | $166.83 M(+10.3%) |
| Dec 2016 | $151.23 M(+67.4%) | $151.23 M(+43.3%) |
| Sep 2016 | - | $105.52 M(-2.1%) |
| Jun 2016 | - | $107.83 M(+16.8%) |
| Mar 2016 | - | $92.32 M(+2.2%) |
| Dec 2015 | $90.34 M(+173.0%) | $90.34 M(+3.1%) |
| Sep 2015 | - | $87.63 M(-9.1%) |
| Jun 2015 | - | $96.45 M(-6.3%) |
| Mar 2015 | - | $102.88 M(+268.7%) |
| Dec 2014 | - | $27.91 M(-15.7%) |
| Sep 2014 | $33.10 M(+1511.3%) | $33.10 M(-21.0%) |
| Jun 2014 | - | $41.91 M(-6.2%) |
| Mar 2014 | - | $44.69 M(+5668.3%) |
| Dec 2013 | - | $774.70 K(-62.3%) |
| Sep 2013 | $2.05 M(-117.0%) | $2.05 M |
| Sep 2012 | -$12.10 M | - |
FAQ
- What is Eagle Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual shareholders equity year-on-year change?
- What is Eagle Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Eagle Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of EGRX is $233.56 M
What is the all time high annual shareholders equity for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual stockholders equity is $233.56 M
What is Eagle Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, EGRX annual stockholders equity has changed by +$57.11 M (+32.36%)
What is Eagle Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of EGRX is $252.04 M
What is the all time high quarterly shareholders equity for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly stockholders equity is $252.04 M
What is Eagle Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, EGRX quarterly stockholders equity has changed by +$14.06 M (+5.91%)